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AMBRA1 is able to induce mitophagy via LC3 binding,
regardless of PARKIN and p62/SQSTM1
This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue.
F Strappazzon1,2, F Nazio1, M Corrado1,3, V Cianfanelli2,4, A Romagnoli5, GM Fimia5,6, S Campello1, R Nardacci5,
M Piacentini2,5, M Campanella7,8 and F Cecconi*,1,2,4
Damaged mitochondria are eliminated by mitophagy, a selective form of autophagy whose dysfunction associates with
neurodegenerative diseases. PINK1, PARKIN and p62/SQTMS1 have been shown to regulate mitophagy, leaving hitherto
ill-defined the contribution by key players in ‘general’ autophagy. In basal conditions, a pool of AMBRA1 – an upstream
autophagy regulator and a PARKIN interactor – is present at the mitochondria, where its pro-autophagic activity is inhibited by
Bcl-2. Here we show that, upon mitophagy induction, AMBRA1 binds the autophagosome adapter LC3 through a LIR
(LC3 interacting region) motif, this interaction being crucial for regulating both canonical PARKIN-dependent and -independent
mitochondrial clearance. Moreover, forcing AMBRA1 localization to the outer mitochondrial membrane unleashes a massive
PARKIN- and p62-independent but LC3-dependent mitophagy. These results highlight a novel role for AMBRA1 as a powerful
mitophagy regulator, through both canonical or noncanonical pathways.
Cell Death and Differentiation (2015) 22, 419–432; doi:10.1038/cdd.2014.139; published online 12 September 2014
Autophagy is an important eukaryotic process involved in the
lysosomal degradation of cytosolic components in both
physiological and pathological conditions. During autophagy,
the autophagosomes  specific double-membraned vesicles
 engulf a number of different cargoes and then fuse with the
lysosomes for subsequent recycling of their content. Several
key proteins are involved in autophagosome formation, such
as BECLIN 1 and its positive regulator AMBRA1;1,2 a pool of
AMBRA1 is localized at the mitochondria, where its pro-
autophagic activity is inhibited by mitochondrial resident
Bcl-2.3 Interestingly, mitochondria have been described as a
source for autophagosome biogenesis;4 they play a key role
in the cross-talk between autophagy and apoptosis regulation
and they are involved in the cell death versus survival decision
(reviewed in Strappazzon et al.3).
Another mechanistic link exists between autophagy and
mitochondria in mammals. Indeed, mitochondria damaged by
the uncoupler CCCP (carbonyl cyanidem-chlorophenyl hydra-
zone)  because of a loss of their mitochondrial membrane
potential (DCm)  are subjected to a form of selective
autophagy, termed mitophagy.5–7 During this process, depo-
larized mitochondria are ubiquitylated; they then recruit p62 (a
protein involved in linking polyubiquitinated protein aggregates
to the autophagic machinery) and next they are transported
along microtubules to the perinuclear region, where they form
rough aggregate structures termed ‘mito-aggresomes’,8–10
a step preceding their lysosomal degradation.
Although mitophagy has been described in a number of
tissues and in various physiological or pathological condi-
tions (reviewed in Andreux et al.11), very few are the known
molecular mechanisms that regulate mitophagy; this is
despite the fact that its manipulation may represent a
forefront strategy in several human diseases. Thus, rather
scarse is yet the availability of chemicals and drug
candidates to modulate the process. The autophagy
receptor NIX and the kinase Ulk1 mediate developmental
removal of mitochondria during retyculocyte differentia-
tion.6,12,13 Smurf1 has been defined as a new recognized
mediator of both viral autophagy and mitophagy.14 In
contrast, the E3 ubiquitin ligase PARKIN and the Ser/Thr
kinase PINK1, both found to be mutated in autosomal
recessive forms of Parkinson’s disease (PD), regulate
mitophagy after mitochondrial damage.5 In more detail,
PINK1 recruits PARKIN to depolarizedmitochondria in order
to remove damaged mitochondria. This mitochondrial
quality control, driven by PINK1/PARKIN proteins, has
recently been better characterized by RNAi screens.15
In fact, new proteins such as HSPA1L, BAG4 and SIAH3
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have been found to modulate translocation of PARKIN to
damaged mitochondria, whereas TOMM7 stabilizes PINK1
on the mitochondria. Interestingly, it has been demonstrated
that after mitochondrial depolarization, the cytosolic pool of
AMBRA1 interacts with PARKIN to enhance mitochondrial
clearance.16
In this study, we investigate the molecular mechanism(s)
responsible for the AMBRA1-dependent enhancement of
PARKIN-mediated mitophagy. We describe for the first time
AMBRA1 as a new LIR (LC3 interacting region)-containing
protein, and we demonstrate that this motif is essential for
the binding between AMBRA1 and LC3, following mitophagy
induction. Furthermore, we show that this interaction is
crucial in a number of cell systems in order to both amplify
PARKIN-mediated mitochondrial clearance and regulate
PARKIN-independent mitophagy. In addition, to better
understand the role of AMBRA1 at the mitochondria and as
AMBRA1 does not possess a clear mitochondrial targeting
sequence, we generated and expressed an organelle-
targeted mutant of AMBRA1 in two different cell systems.
Our data indicate that mitochondrial AMBRA1 induces (1)
relocalization of the mitochondrial network around the
nucleus, (2) depolarization and ubiquitylation of mitochon-
dria and (3) recruitment of the molecular platform necessary
to induce functional mitophagy through a PARKIN/p62-
independent pathway.
This work thus places AMBRA1 as a central player
of mitophagy: we suggest that this molecule facilitates
mitochondrial clearance by bringing damaged mitochondria
onto autophagosomes via its LIR-mediated LC3 interaction.
In addition, we show that high levels of mitochondrial
AMBRA1 trigger mitophagy, a finding that could herald new
therapies to fight important human disorders, ranging from
muscle dystrophy to neurodegeneration.
Results
FCCP induces AMBRA1 binding to LC3 through a
previously undisclosed LIR motif, this enhancing PAR-
KIN-mediated mitophagy. As AMBRA1 can localize at the
mitochondria,3 and as this organelle has been described as a
source for autophagosome biogenesis,4 we checked whether
AMBRA1 could bind LC3, an autophagosome cargo adapter,
on the mitochondria, so as to enhance autophagosome
production following mitochondrial damage.
The known consensus sequence for the core LIR motif is
W/F/Y-x-x-L/I/V.17 Therefore, first of all, we examined in silico
the AMBRA1 sequence and found that AMBRA1 possesses,
indeed, a putative LIR motif in its C-terminal region
(1012SGVEYYWxxL1023). Primed by the hypothesis that
the two factors could interact only locally at a subcellular
level, we enriched our samples for mitochondrial proteins, by
performing a mitochondrial fractioning assay in HEK293 cells
transiently overexpressing myc-AMBRA1WT and after
treatment with FCCP (trifluorocarbonylcyanide phenylhydra-
zone, 1 h, 10 mM), a routinely adopted inducer of mitochondrial
depolarization in in vitro assays. We then precipitated
myc- AMBRA1WT, and we checked for the presence of LC3-
I and -II (hallmarks of autophagy). Interestingly,
myc- AMBRA1WT can be found associated with LC3-I and -II
forms following FCCP treatment in both endogenous and
overexpression conditions (Figure 1a and Supplementary
Figure 1). It is noteworthy that no binding between AMBRA1
and LC3 could be found in total extracts of HEK293
cells following autophagy induction (EBSS treatment,
Supplementary Figure 1b).
It is noteworthy that point mutations of both an aromatic
residue and the conserved hydrophobic residue of the
putative LIR motif (AMBRA1LIR-AA (W1019A-L1022A)
SGVEYYAxxA) almost abolished the interaction between
myc-AMBRA1WT and endogenous LC3 after mitophagy
induction (Figure 1b). Next, as AMBRA1 overexpression has
been shown to enhance PARKIN-mediated mitochondrial
clearance,16 we set out to verify whether AMBRA1–LC3
interaction was required in this context. To this aim, we
transiently coexpressed a vector encoding PARKIN and
AMBRA1WT or AMBRA1LIR-AA in HEK293 cells. We then
treated cells with FCCP in order to induce mitophagy, and
then measured the expression of MnSOD, a mitochondrial
marker. As shown in Figure 1c, overexpression of
AMBRA1WTpotentiates PARKIN-mediated mitophagy,
confirming previous results.16 In contrast, coexpression
Figure 1 FCCP induces AMBRA1 binding to LC3 through a previously undisclosed LIR motif, enhancing PARKIN-mediated mitophagy. (a) HEK293 cells transfected with
a vector encoding myc-AMBRA1WT. At 24 h after transfection, cells were treated with DMSO (ctrl) or with FCCP for 1 h (10 mM). Mitochondrial extracts were
immunoprecipitated using an anti-myc antibody or with IgG control. Purified complexes and corresponding total extracts were analysed by western blot (WB) using anti-
AMBRA1 and anti-LC3 antibodies. (b) Identification of a LIR motif within the AMBRA1 sequence. Point mutations of both an aromatic residue and the conserved hydrophobic
residue are shown (AMBRA1-LIRAA (W1019A-L1022A SGVEYYAxxA)). HEK293 cells were transfected with a vector encoding myc-AMBRA1WTor myc-AMBRA1-LIRAA.
At 24 h after transfection, cells were treated with DMSO (ctrl) or FCCP for 1 h (10 mM). Mitochondrial extracts were immunoprecipitated using an anti-myc antibody or with IgG
control. Purified complexes and corresponding total extracts were analysed by WB using anti-AMBRA1 and anti-LC3 antibodies. The band density ratio of immunoprecipitated
AMBRA1 relative to immunoprecipitated LC3 is analysed in three independent experiments; each point value represents the mean±S.D. from three independent
experiments. Statistical analysis was performed using Student’s test (*Po0.05) versus AMBRA1. (c) HEK293 cells were transfected with a vector encoding myc-AMBRA1WT
or myc-AMBRA1-LIRAA. At 24 h after transfection, cells were treated with DMSO (ctrl) or FCCP for 9 h (1mM). Protein extracts were analysed using anti-MnSOD and anti-
ACTIN (loading control) antibodies. The graph illustrates the MnSOD/ACTIN ratio (±S.D.). Each point value represents the mean±S.D. from three independent
experiments. Statistical analysis was performed using Student’s test (*Po0.05) versus AMBRA1þPARKIN. (d) ETNA cells were transfected with a vector encoding myc-
AMBRA1WTor myc-AMBRA1LIR-AA. At 24 h after transfection, cells were treated with DMSO (ctrl) or FCCP for 5 h (30 mM). Protein extracts were analysed using anti-MnSOD
(mitochondria) and anti-ACTIN (loading control) antibodies. The graph illustrates the MnSOD/ACTIN ratio decrease following FCCP treatment (%). Each point value
represents the mean±S.D. from three independent experiments. Statistical analysis was performed using Student’s test (*Po0.05) versus AMBRA1WT. (e) Ultrastructural
analysis of brain from wild-type and Ambra1gt/gt embryos. The arrow (in the Ambra1gt/gt panel) indicates alterations of the cristae and the overall structure of the organelle in
damaged mitochondria. Protein extracts from embryo heads (E13.5) were analysed by WB using anti-MnSOD, anti-TOM20 and anti-ACTIN (loading control) antibodies.
Magnification is indicated ( ). Graphs represent MnSOD/ACTIN or TOM20/ACTIN ratio (±S.D.). Each point value represents the mean±S.D. from three independent
experiments. Statistical analysis was performed by Student’s test (*Po0.05)
AMBRA1 regulates mitophagy
F Strappazzon et al
420
Cell Death and Differentiation
of PARKIN with AMBRA1LIR-AA did not increase mitochondrial
clearance to the same extent as AMBRA1WT.
Next, we confirmed our results in a murine proneural cell
line. We transiently coexpressed vectors encoding pcDNA3,
AMBRA1WTor AMBRA1LIR-AA in embryonic telencephalic
naive cells (ETNA).18 We then treated cells with FCCP, as
in Figure 1c, and obtained even more striking results
(Figure 1d).
Taken overall, these results indicate that, in different cell
types, the LIR motif of AMBRA1 required for LC3 binding is
AMBRA1WT (1019-1022) SGVEYYWxxL
AMBRA1LIR-AA (W1019A-L1022A) SGVEYYAxxA
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responsible for the described enhancement of PARKIN-
mediated mitochondrial clearance.16
To investigate the mitophagic role of AMBRA1 in vivo in
physiological conditions, we looked at the mitochondrial
content of embryonic forebrains (prosencephalon) from
wild-type or AMBRA1-deficient embryos (Ambra1gt/gt).
As revealed by ultrastructural analysis using electron
microscope (EM), brains from Ambra1gt/gt embryos
accumulated damaged mitochondria when compared with
wild-type tissues. In addition, we observed a stronger
expression of the two mitochondrial markers MnSOD and
TOM20 in Ambra1gt/gt embryonic brains (Figure 1e). These
results support a crucial role, in vivo, for AMBRA1 in
mitochondrial homeostasis.
High levels of mitochondria-targeted AMBRA1 specifi-
cally induce a perinuclear distribution of mitochondria.
To manipulate the dosage of the AMBRA1 mitochondrial
pool, we generated a construct encoding myc-AMBRA1
fused to an ‘insertion sequence’ that can target the molecule
to the outer mitochondrial membrane. To this end, we used a
DNA sequence from the Listeria monocytogenes Actin
assembly-inducing protein (ActA).19
First, we checked for the localization of the AMBRA1–ActA
protein. As expected, AMBRA1–ActA is enriched in the
mitochondrial fraction of HEK293 cells (Figure 2a).
To confirm these results we performed a confocal micro-
scopy analysis in HEK293 cells co-transfected with a vector
encoding fluorescent mito-RFP, in order to stain the
mitochondrial network, and a tagged vector encoding
AMBRA1–ActA. Indeed, AMBRA1–ActA surrounds swollen
and aggregated mitochondria (Figure 2b). In contrast, only a
slight colocalization of AMBRA1–ActA was found with the ER
network (Figure 2b, upper and mid panels). AMBRA1WT only
partially colocalizes with mitochondria (Figure 2b, lower
panels).
Most importantly, we observed that AMBRA1–ActA over-
expression induces per se a strong relocalization of the
mitochondrial network around the perinuclear envelope,
leading to the formation of structures similar to those
previously described as ‘mito-aggresomes’8,10 (Figure 2b,
upper panels). These structures cannot be found after
overexpression of Bcl-2–ActA (Supplementary Figure 2),
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Figure 2 AMBRA1–ActA colocalizes with mitochondria and induces the
formation of ubiquitin-and p62-positive mito-aggresomes in HEK293 cells.
(a) HEK293 cells were transfected with a vector encoding myc-AMBRA1–ActA.
At 24 h after transfection, cells were lysed and mitochondrial extracts were analysed
by western blot using an anti-myc antibody. The fraction purity was verified by
means of antibodies against MnSOD (mitochondria) or GAPDH (cytosol).
The longer exposure in the right panel shows the low levels of Ambra1–ActA
outside mitochondria. (b) HEK293 cells were co-transfected with vectors encoding
myc-AMBRA1–ActA (green) and mito-RFP (red) or ER-DsRed (red). As a control,
HEK293 cells were co-transfected with vectors encoding myc-AMBRA1WT and
mito-RFP. At 24 h after transfection, cells were fixed and stained with an anti-myc
antibody (green). Merge of the fluorescence signals is shown in the right panel,
together with a higher magnification image ( 3). N, nucleus; ERn, ER network;
Mtn, mitochondrial network. Scale bar, 6 mm. (c) HEK293 cells were co-transfected
with vectors encoding myc-AMBRA1-ActA and mito-RFP (red). Twenty-four hours
after transfection, cells were fixed and stained with anti-myc (blue) and anti-Ubiquitin
(green) antibodies. Merged images of the two fluorescence signals are shown in the
right panels. (d) HEK293 cells were co-transfected with vectors encoding myc-
AMBRA1-ActA and mito-RFP (red). Twenty-four hours after transfection, cells were
fixed and stained with anti-myc (blue) and anti-p62 (green) antibodies. Merged
images of the two fluorescence signals are shown in the right panels. N, nucleus.
Scale bar, 6mm.
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confirming that they represent a specific effect of AMBRA1
mitochondrial overexpression.
To summarize, AMBRA1 localization at the outer mitochon-
drial membrane potently induces the formation of structures
similar to mito-aggresomes.
Mitochondria-targeted AMBRA1 induces massive mito-
phagy in PARKIN-competent cells. We next studied the
dynamics of the mitochondria shape changes induced by
AMBRA1. As shown in Supplementary Figure 3, at 8 h after
transfection, AMBRA1–ActA staining significantly overlaps
with the mitochondrial network that seems to be normally well
organized. However, at 10 h after transfection, AMBRA1–
ActA staining in the majority of transfected cells (D75%)
surrounds all mitochondria, forming a sort of ring. Finally, at
18 h after transfection, the mitochondrial network is com-
pletely redistributed around the perinuclear area and forms
mito-aggresome-like structures.
Next, we characterized these structures and found that at
24 h following AMBRA1–ActA overexpression, mitochondria
are stained for ubiquitin and p62 (Figure 2). This observation
suggests that AMBRA1–ActA induces canonical mito-aggre-
somes, decorated by ubiquitin and p62.9,20 The appearance
of mito-aggresomes led us to hypothesize that AMBRA1–
ActA overexpression was able to induce mitophagy. Thus, we
decided to check the occurrence of this event by the presence
of LC3, a well-known marker of autophagosome formation.21
As shown in Figure 5a, a perfect colocalization between
AMBRA1–ActA, mitochondria and LC3 can be observed.
Cells overexpressing AMBRA1–ActA showed a colocalization
ofD82% with ubiquitin,D69% with p62 andD89% with LC3
(see Supplementary Figure 4).
Furthermore, in order to better characterize the mito-
aggresomes as regions with high density of mitochondria-
containing autophagosomes, we performed an ultrastructural
analysis by EM on cells overexpressing AMBRA1–ActA. The
EM image at 24 h indicates the presence of mitochondria
redistributed on one side of the nucleus. At 48 h after
transfection, fewer mitochondria can be observed in whole
cells and engulfment events of mitochondria by autophago-
somes can be found (Figure 3b, 48 hþ magnification panels).
In contrast, after transfection of a vector encoding
AMBRA1WT, no changes in the mitochondrial distribution
are observed (Supplementary Figure 5). To ascertain that
mitophagy was induced by AMBRA1–ActA, we evaluated, by
electronic microscopy, the mitochondria number 48h after
transfection of AMBRA1WT or AMBRA1–ActA. As shown in
the graph (Figure 3b), a third of mitochondria disappeared
upon transfection of AMBRA1–ActA versus AMBRA1WT. To
confirm these data, we checked for mitochondrial proteins at
different time points after AMBRA1–ActA overexpression. As
shown in the graph in Figure 3c, at 48 h after AMBRA1–ActA
overexpression, a third of mitochondria have disappeared,
whereas almost all mitochondria have been degraded at 72 h
after transfection. We can thus conclude that massive
mitophagy is induced by AMBRA1–ActA.
To determine the role of PI3K on mitophagy induced by
AMBRA1–ActA overexpression, HEK293 cells co-transfected
with AMBRA1–ActA and mito-RFP were treated with 10mM
3-MA (3-methyladenine) or 75 nM Wortmannin (two inhibitors
of PI3K22,23). Aggregation of the mitochondrial network was
reduced by treating the cells with 3-MA or Wortmannin
(Figure 3d and Supplementary Figure 6a). Thus, AMBRA1–
ActA-induced mitophagic sequestration seems to depend, at
least in part, on the classical upstreamPI3K pathway.We also
examined the on/off rate of autophagy upon AMBRA1–ActA
overexpression in the presence of a lysosomal-inhibiting
agent, chloroquine. This treatment resulted in a significantly
higher level of mito-aggresomes accumulation in AMBRA1–
ActA-positive cells, hence indicating that autophagosomes
induced by AMBRA1–ActA overexpression are normally
degraded in the lysosome (Figure 3d). In addition, LAMP1/
LC3 colocalization is present in AMBRA1–ActA-overexpres-
sing cells, indicating a canonical lysosomal destination for the
observed mito-aggresomes (Supplementary Figure 6b). We
next confirmed the involvement of the PI3K pathway in
AMBRA1–ActA-induced mitophagy by a more biochemical
approach, that is, by analysing the expression of MnSOD and
TOM20 following AMBRA1–ActA transfection in cells treated
or not with 3-MA andChloroquine. As shown in Figure 3e, both
3-MA and chloroquine treatments block MnSOD and TOM20
decrease following AMBRA1–ActA overexpression. More-
over, downregulation of BECLIN 1, an activator of the PI3K
complex, is able to delay AMBRA1–ActA-induced mitophagy
(Supplementary Figures 6c and d). It is noteworthy that
AMBRA1–ActA overexpression is also sufficient to induce a
massive mitochondrial clearance in the ETNA proneural cell
line (Supplementary Figure 7).
Taken together, these observations demonstrate that
AMBRA1–ActA transfection per se triggers a fully functional
and massive mitophagy in different cell types.
AMBRA1–ActA induces mitophagy independently of
PARKIN and p62 recruitment. To identify the specific
mitophagy pathway induced by AMBRA1–ActA, we decided
to test whether our construct was able to induce mitophagy in
a PARKIN-free system. We used HeLa cells as a cell line
containing no PARKIN (Figure 4a), where AMBRA1–ActA
induces mito-aggresomes (Figure 4b). Then we measured
mitochondria degradation following AMBRA1–ActA over-
expression. As shown in Figure 4c, at 48 h after transfection,
50% of mito-aggresomes disappear, when compared with
the 24 h time point. At 72 h after transfection, it is also difficult
to find cells with mito-aggresomes, and mitochondrial
degradation is almost completed. This finding was also
confirmed by western blot analysis, as revealed by the
decrease of MnSOD and Tom20, two mitochondrial markers,
following AMBRA1–ActA overexpression. Quantification of
the MnSOD/ACTIN ratio indicates that 72 h after AMBRA1–
ActA overexpression, almost all mitochondria are lost
(Figure 4d). These results strongly suggest that AMBRA1–
ActA is also able to induce mitophagy in a PARKIN-deficient
cell line.
To confirm these results, we analysed HEK293 cells in
which PARKIN-mediated autophagy normally takes place and
where PARKIN recruitment to mitochondria also occurs upon
AMBRA1–ActA transfection (Supplementary Figure 8). We
downregulated PARKIN (ShPARKIN, see Figure 4e) and, in
the same cells, we again coexpressed AMBRA1–ActA and
mito-RFP. As shown in Figure 4e, AMBRA1–ActA staining
AMBRA1 regulates mitophagy
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surrounds mitochondria in cells overexpressing either
ShPARKIN or control ShRNA. Our measurement of mito-
chondria degradation at 24, 48 and 72 h post transfection was
also consistent (see graph in Figure 4e). These data were also
confirmed by western blot analysis, by analysing the expres-
sion of MnSOD and TOM20 (Figure 4f).
Next, we decided to look at the formation of mito-
aggresomes following AMBRA1–ActA overexpression in
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HeLa cells. Surprisingly, as shown in Figure 4e, we found that
even though mitochondria are positive for ubiquitin
(Supplementary Figure 9), p62 staining is almost negligible
(at variance with what was observed in HEK293 cells,
see Figure 4b). In more detail, cells overexpressing
AMBRA1–ActA showed a colocalization of D80% with
ubiquitin; D15% with p62 and D87% with LC3
(Supplementary Figure 9).
Altogether, these data strongly suggest that high levels of
AMBRA1 at the mitochondria can also drive this process in a
PARKIN- or p62-independent manner.
AMBRA1–ActA surrounds depolarizedmitochondria. A large
body of evidence indicate that mitochondria depolarization
is a ‘call-out’ signal to start mitophagy.24 Therefore, we set out
to establish whether or not AMBRA1–ActA overexpression
was localized around depolarized mitochondria. We used
Tetramethylrhodamine, methyl ester (TMRM).25 As shown in
Supplementary Figure 10A, AMBRA1–ActA is, indeed, localized
around depolarized mitochondria, with AMBRA1–ActA-overex-
pressing cells showing anD60% reduction in their mitochondrial
potential (see graph), similar to the effect obtained by FCCP
treatment (D80%). Overexpression of a vector coding for
GFP-mito alone does not affect mitochondrial potential
(Supplementary Figure 10B).
These data suggest that AMBRA1–ActA-mediated clear-
ance of mitochondria is summoned into action by depolarized
organelles.
The LIR motif of AMBRA1 is required for AMBRA1–ActA-
induced mitophagy. Given our initial results regarding the
importance of AMBRA1 LIR domain in mitophagy (see
Figures 1c and d), we decided to check the occurrence of
AMBRA1–ActA/LC3 interaction through this domain.
We thus performed an immunoprecipitation between
AMBRA1–ActA and LC3 on mitochondrial fractions. We
found that, in the absence of any known mitophagy inducers,
AMBRA1–ActA interacts with LC3, whereas no interaction
can be found between AMBRA1WT and LC3 (Figure 5a).
Point mutations of both the aromatic residue and
the conserved hydrophobic residue of the LIR motif
(AMBRA1LIR-AA-ActA (W1019A-L1022A SGVEYYAxxA))
suppress the interaction between AMBRA1–ActA and
endogenous LC3 (Figure 5b). In addition, we observed that
AMBRA1LIR-AA–ActA was able to colocalize with the mito-
chondrial network, but not, in contrast to AMBRA1–ActA,
with mito-aggresomes (Figure 5c).
Next, by measuring mitochondria degradation by western
blot analysis, we found that the mitochondrial markers
MnSOD and TOM20 were more stable after transfection of
AMBRA1LIR-AA–ActA when compared with cells overexpres-
sing AMBRA1–ActA (Figure 5d).
Our data indicate that the LIRAA mutation on AMBRA1–
ActA delays mitochondrial clearance. We can thus conclude
that AMBRA1–ActA-driven PARKIN-independent mitophagy
also absolutely requires LC3 binding via the AMBRA1 LIR
domain.
AMBRA1 mediates PINK1–PARKIN-independent mito-
phagy in different cell systems. Finally, to extend our
analysis to the PINK1–PARKIN regulatory axis and to get an
in vivo corroboration of our results, we decided to investigate
whether AMBRA1WTwas able to induce mitochondrial clear-
ance in several systems in which the PINK1–PARKIN
pathway was deficient or absent. To this aim, we recon-
stituted Parkin-Ambra1 double-deficient MEFs (Ambra1gt/gt)
with AMBRA1WT or AMBRA1LIR-AA and treated these cells
with 30 mM FCCP for 9 h, in order to induce mitophagy. As
shown in Figure 6a, AMBRA1WT is able to induce mitochon-
drial clearance, at variance with AMBRA1LIR-AA, that is not
able to promote mitophagy. We next decided to use mouse
embryonic fibroblasts (MEFs) from PINK1 / mice in order
to ascertain that the PINK1–PARKIN pathway was abol-
ished. We overexpressed AMBRA1WT or AMBRA1LIR-AA and
we treated cells with FCCP for 9 h (30 mM). Again, as shown
in Figure 6b, overexpression of AMBRA1WT induces
mitochondrial clearance, whereas overexpression of
AMBRA1LIR-AA did not increase mitochondrial clearance to
Figure 3 AMBRA1–ActA induces mitophagy in HEK293 cells. (a) HEK293 cells were co-transfected with vectors encoding myc-AMBRA1–ActA and mito-RFP (red).
At 24 h after transfection, cells were fixed and stained with anti-myc (blue) and anti-LC3 (green) antibodies. Merge of the two fluorescence signals is shown in the right panel.
Scale bar, 5 mm. (b) An ultrastructural analysis by EM on whole cells. HEK293 cells were co-transfected with vectors encoding myc-AMBRA1–ActA and GFP mitochondria.
At 24 or 48 h after transfection, GFP-positive cells were sorted by using FACS and fixed in glutaraldehyde. Morphological analysis was performed. In the left panel,
mitochondria are already redistributed around the nucleus (24 h following transfection). M, mitochondria. The center panel (48 h following transfection) shows a whole cell
containing less mitochondria than at 24 h. Arrows indicate fragmented mitochondria into autophagosomes. Scale bar, 5mm. The upper and lower panels on the right are two
magnifications of the autophagosomes observed in the whole cell (see arrows in the middle panel, 48 h). Scale bar, 500 nm. The graph shows quantification of mitochondria
number per cells positive for AMBRA1WT and AMBRA1–ActA at 48 h post transfection. Each point value represents the mean±S.D. from three independent experiments.
Statistical analysis was performed using Student’s test (*Po0.05) (c) HEK293 cells were transfected with a vector encoding myc-AMBRA1–ActA. At 24, 48 and 72 h after
transfection, proteins extracts were analysed by western blot using the following antibodies: anti-MnSOD, anti-myc (to control AMBRA1–ActA expression) and anti-ACTIN
(loading control). The graph represents the MnSOD/ACTIN ratio (±S.D.). Each point value represents the mean±S.D. from three independent experiments. Statistical analysis
was performed using Student’s test (*Po0.01; 24 h versus 72 h). (d) 3-MA treatment partially inhibits AMBRA1–ActA/mito-DsRed vacuole formation. HEK293 cells were
co-transfected with vectors encoding AMBRA1–ActA and mito-RFP and treated directly with 10 mM 3-MA. After 24 h, cells were fixed and stained with an anti-myc antibody
(green). Nuclei were stained with 1mg/ml DAPI for 20 min. Merge of the three fluorescence signals is shown in the right panel. Scale bar, 6mm. Chloroquine treatment increases
the percentage of AMBRA1–ActA/mito-RFP colocalizations on mito-aggresomes per cell. HEK293 cells were co-transfected with a vector encoding AMBRA1–ActA and a vector
encoding mito-RFP. After 24 h, cells were treated with chloroquine for 1 h, and cells were fixed and stained with an anti-myc antibody (green). Nuclei were stained with 1mg/ml
DAPI for 20 min. Merge of the three fluorescence signals is shown in the right panel. Scale bar, 6mm. The graph shows the quantification of AMBRA1–ActA/mito-RFP
colocalization on mito-aggresomes per cell (±S.D.). Each point value represents the mean±S.D. from three independent experiments. Statistical analysis was performed using
Student’s test (*Po0.05, no treatment versus Chloroquine; and *Po0.001, no treatment versus 3-MA). N, nucleus. (e) HEK293 cells were co-transfected with vectors encoding
AMBRA1–ActA and mito-RFP and treated directly with 10 mM 3-MA. After 24 h, proteins extracts treated with Chloroquine (1 h) or left untreated were analysed by western blot
using the following antibodies: anti-MnSOD, anti-TOM20, anti-myc (to control AMBRA1–ActA expression) and anti-ACTIN (loading control). The graph represents the MnSOD/
ACTIN ratio (±S.D.). Each point value represents the mean±S.D. from three independent experiments. Statistical analysis was performed using Student’s test (*Po0.05)
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the same extent. To complete our analysis, we next used
primary human cells from a PD patient with PINK1 loss of
function (fibroblasts from Biobank of Genova, Italy). We
introduced lentivirus expressing AMBRA1WTor AMBRA1LIR-AA
in those cells and then treated them with FCCP for 5 h
(40mM). As shown in Figure 6c, overexpression of
AMBRA1WT induces mitochondrial clearance. At variance,
overexpression of AMBRA1LIR-AA did not increase mitochon-
drial clearance to the same extent as AMBRA1WT.
These results indicate that AMBRA1 expression can
partially rescue mitochondrial clearance in different ex vivo
models, including cells from a PD patient. In sum, AMBRA1
can induce mitophagy through its LIR domain, sinergically
with FCCP and in the absence of the PINK1–PARKIN
pathway activity.
Discussion
AMBRA1 binds LC3 following mitophagy induction. We
show that AMBRA1 uses a LIR motif to interact with LC3
following mitophagy induction. This interaction takes place
both upon enhanced levels of AMBRA1 at the mitochondria
and after FCCP treatment joint to PARKIN endogenous
expression or overexpression. Our results thus suggest that
LC3–AMBRA1 interaction is functional to an efficient
mitochondrial clearance, rather than to the capture of
AMBRA1 within the autophagosome in a sort of negative
feedback control of autophagy. However, we cannot exclude
that AMBRA1 is degraded by the autophagosomes in other
conditions. Indeed, several ATG proteins are located on the
outer surface of the phagophores, and some are also located
within the autophagosomes.26–28 The interaction with LC3
may imply that a binding of AMBRA1 with other ATG proteins
on LC3-positive structures could be required for correct
autophagosome maturation.
AMBRA1–ActA induces depolarization and ubiquitylation
of mitochondria. By another set of experiments, we
demonstrate that all mitochondria found to be positive for
AMBRA1–ActA are depolarized. An open question is how
high levels of mitochondrial AMBRA1 would induce mito-
chondrial depolarization. We previously demonstrated that
AMBRA1 could bind mito-Bcl-2.3 Considering all our findings,
we can now postulate that high levels of AMBRA1 at the
mitochondria, by mimicking BH3-only proteins, could
sequester the majority of mito-Bcl-2, thus inducing Bax/Bak
activation and mitochondrial membrane depolarization. As
for the fate of depolarized mitochondria, it is important to bear
in mind that ubiquitin is a signal for selective autophagy in
mammalian cells. In fact, in the PARKIN-induced mitophagy
pathway, PARKIN, an E3-ubiquitin ligase, translocates from
the cytosol to mitochondria in cells treated with CCCP.5,7
After translocation to the depolarized mitochondria, PARKIN
catalyzes polyubiquitylation of several substrates, calling into
play the autophagy receptor p62/SQSTM1 that simulta-
neously binds ubiquitin and autophagy-specific ubiquitin-like
modifiers (LC3/GABARAP proteins).9,20 Here we found that
all mitochondria are ubiquitylated after AMBRA1–ActA over-
expression. As we also found mitochondrial ubiquitin in
PARKIN-deficient cells, AMBRA1–ActA could serve, most
likely, as an adaptor for other E3 ligases. Noteworthy, we
have recently demonstrated that AMBRA1 can bind the E3
ubiquitin ligase TRAF6.29 It will be interesting to investigate
whether the binding between AMBRA1 and TRAF6 is an
important event for mitochondria ubiquitylation. However,
other candidates can help AMBRA1 to ubiquitylate mitochon-
dria. In fact, AMBRA1 has also been found to be associated
in a complex with the CUL4–DDB1 complex.30,31
AMBRA1 mediates PINK1–PARKIN-independent mitophagy.
Another issue is the mechanism by which endogenous
AMBRA1 participates in mitochondrial clearance. We confirm
that AMBRA1 potentiates PARKIN-mediated mitophagy, in
line with previous work.16 We show that AMBRA1–ActA
promotes PARKIN translocation to depolarized mitochondria
in HEK293 cells, where PARKIN is present. However, in
PARKIN-deficient cells, AMBRA1–ActA alone can induce
mitochondrial clearance, indicating that a parallel pathway for
mitophagy may exist when PARKIN is not present. Of the
highest importance, wild-type AMBRA1, in combination with
FCCP treatment, can also induce mitochondrial clearance in
a PARKIN-independent manner, as in Pink1- or Parkin-
deficient mouse fibroblasts or in human fibroblasts in which a
mutant inactive form of PARKIN is present.
Figure 4 AMBRA1–ActA induces mitophagy in PARKIN-deficient cell lines. (a) HeLa and HEK293 cells were grown in normal media. After extraction of proteins, we
performed a western blot analysis by using antibodies against PARKIN and against ACTIN (as a loading control). (b) Colocalization between AMBRA1–ActA, mito-RFP and
LC3 protein. HeLa cells were co-transfected with vectors encoding AMBRA1–ActA and mito-RFP, and grown in normal media. Cells were then stained using antibodies
anti-myc (AMBRA1, blue) and anti-LC3 (green). Nuclei were stained with 1mg/ml DAPI for 20 min. Merge of the different fluorescence signals is illustrated. Scale bar, 8 mm.
(c) Quantification in HeLa cells of AMBRA1–ActA/mito-RFP mito-colocalizations at 24, 48 and 72 h after transfection per cell (±S.D.). Each time point value is the
mean±S.D. from three independent experiments. Statistical analysis was performed using Student’s test (***Po0.001; 24 h versus 72 h). (d) HeLa cells were transfected
with a vector encoding myc-AMBRA1–ActA. At 24, 48 and 72 h after transfection, proteins extracts were analysed by western blot using the following antibodies: anti-MnSOD,
anti-TOM20, anti-myc (to control AMBRA1–ActA expression) and anti-ACTIN (loading control). The graph represents the MnSOD/ACTIN ratio (±S.D.). Each point value
represents the mean±S.D. from three independent experiments. Statistical analysis was performed using Student’s test (**Po0.01; 24 h versus 72 h). (e) HEK293 cells were
co-transfected with vectors encoding ShPARKIN or control ShRNA and myc-AMBRA1-ActA. At 24 h after transfection, expression of PARKIN was controlled by western blot
analysis by means of anti-PARKIN and anti-ACTIN (loading control) antibodies. Cells were fixed and stained with an anti-myc antibody (green). The merge of the fluorescence
signals is shown in the right panels. Scale bar, 4mm. The graph illustrates the quantification of AMBRA1–ActA/mito-RFP colocalizations on mito-aggresomes per cell (±S.D.).
Each point value represents the mean±S.D. from two independent experiments. Statistical analysis was performed using Student’s test (*Po0.01; 24 h versus 72 h).
(f) HEK293 cells were co-transfected with vectors encoding ShPARKIN or control ShRNA, and myc-AMBRA1–ActA. At 24 h after transfection, expression of PARKIN was
checked by western blot analysis by means of anti-PARKIN and anti-ACTIN (loading control) antibodies. At 24, 48 and 72 h after transfection, protein extracts were analysed
by western blot using the following antibodies: anti-MnSOD, anti-TOM20, anti-myc (to control AMBRA1–ActA expression) and anti-ACTIN (loading control). The graph
represents the MnSOD/ACTIN ratio (±S.D.). Each point value represents the mean±S.D. from three independent experiments. Statistical analysis was performed using
Student’s test (*Po0.05; 24 h versus 72 h). (g) HeLa cells were co-transfected with vectors encoding myc-AMBRA1–ActA and mito-RFP (red). At 24 h after transfection, cells
were fixed and stained with anti-myc (AMBRA1, blue) and anti-p62 antibodies (green). Merge of the fluorescence signals are shown. N, nucleus. Scale bar, 4 mm
AMBRA1 regulates mitophagy
F Strappazzon et al
427
Cell Death and Differentiation
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
*
M
nS
O
D/
AC
TI
N 
ra
tio
 
AMBRA1-ActALIR-AA
AMBRA1-ActA 
 
pc
DN
A3
mito-RFP Merge
NNN
To
ta
l e
xt
r. 
AM
BR
A1
-A
ct
A
To
ta
l e
xt
r. 
AM
BR
A1
IP
 A
M
BR
A1
-A
ct
A 
IP
 Ig
G
 C
trl
IP
 Ig
G
 C
trl
m
yc
-ta
gg
ed
pr
ot
ei
ns
 
m
yc
-ta
gg
ed
 
pr
ot
ei
ns
WB AMBRA1
WB LC3
I
II
mitochondrial fractions
IP
 A
M
BR
A1
-A
ct
A 
IP
 Ig
G
 C
trl
IP
 A
M
BR
A1
-A
ct
AL
IR
-A
A
IP
 Ig
G
 C
trl
To
ta
l e
x.
 A
M
BR
A1
-A
ct
A
To
ta
l e
x.
 A
M
BR
A1
-A
ct
AL
IR
-A
A
WB AMBRA1
WB LC3I
II
mitochondrial fractions
 AMBRA1-ActALIR-AA
AM
BR
A1
-A
ct
AL
IR
-A
A
 
AM
BR
A1
-A
ct
AL
IR
-A
A  
AM
BR
A1
-A
ct
A 
 
AM
BR
A1
-A
ct
A 
WB myc
WB MnSOD
WB TOM20
WB ACTIN
myc-tagged
proteins
IP
 A
M
BR
A1
W
T
hours post-transfection
hours post-transfection
0
10
20
30
40
50
60
70
24h
48h
72h
m
ito
-R
FP
 d
ot
s 
pe
r c
el
l p
os
itiv
e
fo
r A
M
BR
A1
-A
ct
AL
IR
-A
A (%
)   
   
0 24 24 48 48
0 24 24 48 48
Figure 5 AMBRA1–ActA interacts with LC3, with this interaction being crucial for AMBRA1–ActA-induced mitophagy. (a) HEK293 cells were transfected with a vector
encoding myc-AMBRA1–ActA. At 24 h after transfection, mitochondrial extracts were immunoprecipitated using an anti-myc antibody. Purified complexes and corresponding
total extracts were analysed by western blot (WB), using anti-AMBRA1 and anti-LC3 antibodies. (b) HEK293 cells were transfected with a vector encoding myc-AMBRA1–
ActA or myc-AMBRA1–ActA-LIRAA. At 24 h after transfection, mitochondrial extracts were immunoprecipitated using an anti-myc antibody. Purified complexes and
corresponding total extracts were analysed by WB using anti-AMBRA1 and anti-LC3 antibodies. (c) HEK293 cells were transfected with a vector encoding myc-AMBRA1–
ActA-LIRAA and mito-RFP. At 24 h hours after transfection, cells were fixed and stained with an anti-myc antibody (green). Merge of the fluorescence signals is shown in the
right panels. Scale bar, 8 mm. The graph reports the quantification of mitochondrial clearance in HEK293 cells overexpressing AMBRA1–ActALIR-AA/mito-RFP at 24, 48 and
72 h after transfection per cell (±S.D.). Each time point value is the mean±S.D. from three independent experiments. (d) HEK293 cells were transfected with a vector
encoding myc-AMBRA1–ActA-LIRAA. At 0, 24 and 48 h after transfection, protein extracts were analysed using anti-MnSOD, anti-myc (AMBRA1) and anti-ACTIN (loading
control) antibodies. The graph represents the MnSOD/ACTIN ratio (±S.D.). Each point value represents the mean±S.D. from three independent experiments. Statistical
analysis was performed by Student’s test (*Po0.05; 0 h versus 48 h)
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In sum, it is certainly possible that different mitophagy
pathways coexist, depending on the inducing conditions or the
cell type. Moreover, we found a new mechanism accounting
for the effect of AMBRA1 on PARKIN-mediated mitophagy. In
fact, AMBRA1 binding to LC3 increases mitochondrial
clearance. In the absence of PARKIN, we also found a
binding between AMBRA1 and LC3 after AMBRA1–ActA
overexpression. Therefore, in the absence of PARKIN,
AMBRA1 could be proposed as a selective mitophagy
receptor, similar to the factor Atg32 in yeast.32,33
Interestingly, it has recently been demonstrated that
BECLIN 1 interacts with PARKIN and regulates PARKIN
translocation to mitochondria.34 As we show that down-
regulation of BECLIN 1 reduces AMBRA1–ActA-induced
mitophagy, it would be interesting to investigate the role of
BECLIN 1 in AMBRA1–ActA-induced mitophagy. We can
hypothesize that BECLIN 1 is functional to bring a putative E3
Ubiquitin ligase (alternative to PARKIN) in order to ubiquitylate
mitochondria in AMBRA1–ActA-induced mitophagy.
AMBRA1–ActA is a powerful inducer of mitophagy.
Hitherto, in mammalian cells, overexpression of PARKIN in
combination with CCCP treatment is the only known method
to induce mitophagy. We have now been able to prove that
targeting AMBRA1 to mitochondria is sufficient to induce
massive mitochondrial clearance. The next step will be to
check whether AMBRA1–ActA induces mitophagy in vivo,
this being of the highest importance in biomedicine.
Furthermore, given the fact that AMBRA1 has a LIR motif
used for its binding to LC3 during mitophagy, it would be
interesting to investigate whether AMBRA1 could be mutated
in this domain in neurodegenerative conditions, such as in
PD. Similar mutations may also be associated with the risk of
developing PD. At the same time, it could also be important
to check AMBRA1 levels in other human disorders in which
mitophagy is deregulated, such as muscular dystrophies.35
Materials and Methods
Antibodies. The antibodies used were as follows: polyclonal anti-PARKIN
(Santa Cruz Biotechnology, Santa Cruz, CA, USA, H-300- sc-30130, Abcam,
Cambridge, UK, 15954), mouse monoclonal anti-ACTIN (Sigma-Aldrich, St. Louis,
MO, USA), monoclonal anti-BCL-2 (Santa Cruz Biotechnology, sc-7382),
polyclonal anti-MnSOD (Assay Designs, Danvers, MA, USA), polyclonal anti-
AMBRA1 (Novus Biologicals, Littleton, CO, USA, 26190002), polyclonal anti-LC3
(Cell Signaling, Danvers, MA, USA), monoclonal anti-GAPDH and rabbit
polyclonal anti-LAMP1 (Abcam 24170).
Cells. The human embryonic kidney HEK293 cells and HeLa cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich) supplemented
with 10% FCS, 2 mM L-glutamine, and 1% penicillin/streptomycin solution at 37 1C
under 5% CO2. MEFs cells were cultured in DMEM supplemented with 10% fetal
bovine serum (FBS, Sigma-Aldrich), 2 mM L-glutamine and 1% penicillin/
streptomycin solution at 37 1C. Cells were incubated in the presence of 30 mM
FCCP (Sigma-Aldrich) for 9 h. Human fibroblasts (code: FFF0592011, Biobank
Genova, Laboratorio di diagnosi Prenatale, Ist. Gaslini, Genova, Italy, kind gift of
Dr. Filocamo) were obtained from a man bearing a mutation in the PINK1 gene,
who developed PD when he was 40 years old (early-onset form of the disease).
Human fibroblasts were then cultured in RPMI-140 medium supplemented with
10% FBS (Sigma-Aldrich), 2 mM L-glutamine and 1% penicillin/streptomycin
solution at 37 1C. Pink1 / mice were jointly provided by Professor Jie Shen
(Harvard Medical School, Boston MT, USA) and Professor Antonio Pisani (IRCCS,
Fondazione Santa Lucia, Roma, Italy). MEFs derived from Pink1 / embryos at
day 13.5 p.c. were grown in DMEM supplemented with 10% FBS (Sigma-Aldrich),
2 mM L-glutamine and 1% penicillin/streptomycin solution at 37 1C.
Cloning and plasmids. To create AMBRA1–ActA fusion gene, we first
amplified by PCR, with PfuTurbo DNA polymerase, the oligonucleotides
corresponding to aa 613–639 of Listeria ActA, using a vector encoding Bcl-2-
ActA (a kind gift of Dr. Beth Levine, Dallas, TX, USA). The AMBRA1 coding region
has also been generated by PCR with PfuTurbo DNA Polymerase, using wild-type
myc-AMBRA1. Next, we digested these two PCR products with two restriction
enzymes ApaI and HindIII, respectively, and then they were cloned into PcDNA3
vector (Invitrogen, Carlsbad, CA, USA). Construct coding for AMBRA1WT was
cloned in pLPCX vector (Clontech Laboratories, Mountain View, CA, USA).
Point mutations were generated using the QuickChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA, USA) and all plasmid constructs made in this study were
verified by DNA sequencing (Eurofins, Rome, Italy). The oligonucleotides used for
mutagenesis, PCR and DNA sequencing were purchased from Invitrogen.
ShRNA PARKIN. ShRNA PARKIN (PGIP2 449497) or shRNA Control
(PGIP2 ) were transfected in HEK293 cells using Turbofect Transfection reagent
(Fermentas, Thermo Fisher Scientific, Waltham, MA, USA, R0531), according to
the manufacturer’s instructions. At 24 or 48 h after transfection, PARKIN
expression was controlled by western blot analysis.
Lentiviral production and infection. AMBRA1 cDNAs, wild-type and
mutant, were subcloned from pLPCX, by cutting with NheI and NotI (blunted)
restriction enzymes and transferred into the pRRL lentiviral plasmid digested with
XbaI and SalI (blunted). For AMBRA1 ectopic expression in MEFs, lentiviral
particles were produced by transfecting HEK293T cells with the lentiviral vector
pRRLsinPPT.CMV.WPRE (Follenzi et al.36) encoding AMBRA1WT or AMBRA1-
mutant (AMBRA1-LIRAA), together with the pMDLg/pRRE, pMD2.G and pRSV-Rev
plasmids. Supernatants were collected 48 h post transfection. The lentiviral
suspension was supplemented with polybrene (4mg/ml, Sigma-Aldrich), filtered
(PES 0.45mM filters, Corning, Santa Clara, CA, USA) to remove cell debris and
incubated with target cells for 8–12 h. To increase the transduction efficiency, the
infection was repeated twice. Infected cells were then analysed starting from 48 h
after infection.
Reagents. 3-Methyladenine, Chloroquine and wortmannin were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). TMRM (cat. no. T668) was
obtained from Invitrogen/Molecular Probes (Carlsbad, CA, USA). FCCP was from
Sigma.
Western blot analysis. Cell extracts were centrifuged at 13 000 g for 10 min
at 4 1C. Protein concentrations were determined with the Bio-Rad Protein Assay
(Bio-rad Laboratories, Hercules, CA, USA). Cell extracts or immunoprecipitates
were separated by SDS-PAGE and transferred onto nylon membranes (Immobilon
P, Millipore, Bedford, MA, USA). Membranes were incubated with primary
antibodies followed by horseradish peroxidase-conjugate secondary antibody
(Jackson Laboratories, Ann Arbor, MI, USA) and visualized with ECL plus
(Amersham Bioscience, Little Chalfont, UK).
Figure 6 Wild-type AMBRA1, in combination with FCCP, induces mitophagy independently of the PINK1–PARKIN pathway. (a) Mouse embryonic fibroblasts (MEFs)
homozygous (Ambra1gt/gt) for the gene-trap mutation in the Ambra1 locus were transduced with the AMBRA1WT or AMBRA1LIR-AA lentiviral vectors. MEFs were next treated
with FCCP (30 mM) for 9 h in order to induce mitophagy. Protein extracts were analysed by western blotting using anti-AMBRA1, anti MnSOD and anti-ACTIN antibodies. The
graph shows the MnSOD/ACTIN ratio decrease (±S.D.). Each point value represents the mean±S.D. from three independent experiments. Statistical analysis was
performed using Student’s test (*Po0.05, versus AMBRA1). (b) Pink1 / MEFs were transduced with the GFP, AMBRA1WT or AMBRA1LIR-AA lentiviral vectors. MEFs were
next treated with FCCP (30 mM) for 9 h in order to induce mitophagy. Protein extracts were analysed by western blotting as in (a). (c) Primary skin fibroblasts from a patient
affected by an early-onset form of PD (mutation in Pink1 gene) were transduced with the GFP, AMBRA1WT or AMBRA1LIR-AA lentiviral vectors. MEFs were next treated with
FCCP (40mM) for 6 h in order to induce mitophagy. Protein extracts were analysed by western blotting as in (a)
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Immunocytochemistry. Cells were washed in PBS and fixed with 4%
paraformaldehyde in PBS for 15 min. After permeabilization with 0.4% Triton
X-100 in PBS for 5 min, cells were blocked in 3% normal goat serum in PBS and
incubated overnight at 4 1C with primary antibodies. We used the antibodies
directed against AMBRA1, PARKIN and LC3. Cells were then washed in blocking
buffer and incubated for 1 h with labelled anti-mouse (Alexa Fluor 488 or Alexa
Fluor 555, Molecular Probes, Eugene, OR, USA) or anti-rabbit (FITC or Cy3,
Jackson ImmunoResearch, West Grove, PA, USA) secondary antibodies.
Nuclei were stained with 1 mg/ml DAPI and examined under a Zeiss LSM 700
100 oil-immersion objective (Zeiss, Oberkoechen, Germany). We used ‘ZEN
2009 Light edition’ software for image analysis. All measurements in this work
were performed by a blind approach. All colocalization analyses were performed in
nonsaturated single z-confocal planes.
Mitochondria purification. Mitochondria were isolated from HEK293
cells by standard differential centrifugation, and suspended in isolation buffer
(IB; 0.2 M sucrose, 10 mM Tris-MOPS (pH 7.4), 0.1 mM EGTA-Tris and 0.1%
delipidated BSA).
Immunoprecipitation. Cells were lysed in RIPA buffer (plus protease
inhibitors). Equal amounts of protein (500mg) were incubated with 2ml of
monoclonal anti-Myc antibody conjugated with protein A agarose beads (Clontech
and Sigma, respectively) for 4 h followed by 60 min incubation with 30 ml of protein
A Sepharose beads (Roche, Boulogne-Billancourt, France). The beads were
collected by centrifugation and washed four times with the RIPA buffer. Proteins
bounds to the beads were eluted with 30 ml of SDS-polyacrylamide gel
electrophoresis sample buffer and heated to 95 1C for 10 min.
Electron microscopy. For conventional EM, HeLa cells previously trans-
fected with AMBRA1–ActA and mito-GFP were sorted 24 or 48 h after transfection
and fixed with 2.5% glutaraldehyde buffered with 0.1 M sodium phosphate, pH 7.4.
Samples were postfixed with osmium tetroxide, then stained with uranyl acetate,
dehydrated in ethanol and embedded in Epon resin (Fluka, Sigma-Aldrich). After
sectioning, samples were collected on uncoated nickel grids and observed and
photographed in a Technai 20 (FEI Company, Eindhoven, The Netherlands) EM.
Embryos lysis heads. Heads of embryos from stage E13.5 were subjected
to mechanical lysis in 50 mM Tris HCl pH 7.5, 320 mM Sucrose, 50 mM NaCl, 1%
Triton X-100 and protease inhibitors. Protein extracts were analysed by western
blot analysis.
Ultrastructural analysis of brain from wild-type and Ambra1gt/gt
embryos. The embryos (E13.5) were extracted from the deciduas and fixed by
immersion in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, for 45 min at
4 1C, rinsed in buffer, postfixed in 1% OsO4 in 0.1 M cacodylate buffer, pH 7.4,
dehydrated and embedded in Epon resin. Grids were thoroughly rinsed in distilled
water, stained with aqueous 2% uranyl acetate for 20 min and photographed in a
Zeiss EM 900 EM.
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